当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:311.91亿  总市值:471.11亿
流通股本:5.78亿   总股本:8.72亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润21.50亿元,每股收益2.34元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益2445356.21万元,未分配利润877479.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产2968074.23万元,负债522718.02万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入7,384,039,460.885,650,477,938.013,710,850,371.591,804,571,375.28
营业总成本5,554,124,713.544,142,186,555.142,720,025,504.931,360,291,377.24
营业利润2,486,940,557.422,311,724,272.621,598,597,788.22630,897,782.9
利润总额2,488,533,058.162,314,469,415.051,599,145,093631,062,128.03
净利润2,149,926,843.572,027,846,971.741,408,089,992.74568,325,660.27
其他综合收益53,516,065.6966,970,735.88103,163,104.24-46,553,885.08
综合收益总额2,203,442,909.262,094,817,707.621,511,253,096.98521,771,775.19
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计11,344,141,125.2111,465,404,979.7311,976,418,436.111,215,264,660.87
非流动资产合计18,336,601,223.9618,607,044,433.1317,690,257,295.9616,956,863,039.12
资产总计29,680,742,349.1730,072,449,412.8629,666,675,732.0628,172,127,699.99
流动负债合计4,138,736,291.584,272,088,045.834,633,250,533.093,796,994,945.76
非流动负债合计1,088,443,912.331,249,127,842.731,075,575,608.781,056,587,898.51
负债合计5,227,180,203.915,521,215,888.565,708,826,141.874,853,582,844.27
归属于母公司股东权益合计21,026,774,725.7521,059,877,997.1720,586,103,937.2720,145,013,394.15
股东权益合计24,453,562,145.2624,551,233,524.323,957,849,590.1923,318,544,855.72
负债和股东权益合计29,680,742,349.1730,072,449,412.8629,666,675,732.0628,172,127,699.99
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计7,095,305,409.425,303,391,474.823,498,591,573.611,630,343,450.42
经营活动现金流出小计5,944,867,467.374,630,746,993.263,123,550,318.271,601,835,231.02
经营活动产生的现金流量净额1,150,437,942.05672,644,481.56375,041,255.3428,508,219.4
投资活动现金流入小计1,293,893,974.05730,707,309.57404,985,024.55253,191,614.58
投资活动现金流出小计2,828,118,716.522,323,212,158.131,113,544,944.53800,704,436.15
投资活动产生的现金流量净额-1,534,224,742.47-1,592,504,848.56-708,559,919.98-547,512,821.57
筹资活动现金流入小计3,596,068,529.073,057,685,789.541,703,330,972.76543,861,589.04
筹资活动现金流出小计3,603,874,589.352,582,824,548.021,082,260,769.84241,700,346.81
筹资活动产生的现金流量净额-7,806,060.28474,861,241.52621,070,202.92302,161,242.23
汇率变动对现金及现金等价物的影响8,793,343.5322,207,055.1425,879,265.82-11,111,360.82
现金及现金等价物净增加额-382,799,517.17-422,792,070.34313,430,804.1-227,954,720.76
期末现金及现金等价物余额7,399,941,369.857,359,948,816.688,096,171,691.127,554,786,166.18
TOP↑